Company Analysis

Universe Pharmaceuticals Inc. (UPC)

Nasdaq: UPC · Pharmaceutical Preparations · Ji'An, Jiangxi, CN · filing with the SEC since 2020
Grade6.0
◀ Past 6.0● Present 6.7▶ Future 5.1
2 est.

Who runs Universe Pharmaceuticals Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Lai Gang
Chief Executive Officer. First filing Mar 2026, latest May 21, 2026, 0 filings in all.
Officers reporting now
3
of 6 people with a filing in the last fifteen months
Directors reporting now
3
6 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Lai GangChief Executive OfficerMar 2026May 21, 2026none
Yang Lin (Lydia)Chief Financial OfficerMar 2026Mar 18, 2026none
Liu BaochangChief Operating OfficerMar 2026Mar 18, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Pang JiawendirectorMar 2026Mar 18, 2026none
Yu YongpingdirectorMar 2026Mar 18, 2026none
Zheng DingdirectorMar 2026Mar 18, 2026none

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton UPC · research, not advice